Michaelr Megna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michaelr megna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michaelr Megna Today - Breaking & Trending Today

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30.00 at JPMorgan Chase & Co.

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30.00 at JPMorgan Chase & Co.
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Michaelr Megna , Sanjk Patel , Victory Capital Management Inc , Sg Americas Securities , Hedge Funds Weigh In On Kiniksa Pharmaceuticals , News Ratings For Kiniksa Pharmaceuticals Daily , Kiniksa Pharmaceuticals Company Profile , Insider Activity At Kiniksa Pharmaceuticals , Capital Management Inc , Jpmorgan Chase Co , Kiniksa Pharmaceuticals , Dynamic Technology Lab Private Ltd , Kiniksa Pharmaceuticals Trading , Kiniksa Pharmaceuticals Ltd , China Universal Asset Management Co , Free Report , Get Free Report , Universal Asset Management , Capital Management , Technology Lab Private Ltd , Kiniksa Pharmaceuticals Daily ,

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30.00

Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) had its price target raised by Evercore ISI from $25.00 to $30.00 in a research report report published on Wednesday morning, Benzinga reports. Evercore ISI currently has an outperform rating on the stock. A number of other equities research analysts have also commented on KNSA. Wedbush restated an outperform […] ....

Michaelr Megna , Advisors Inc , Capital Management Inc , Kiniksa Pharmaceuticals , News Ratings For Kiniksa Pharmaceuticals Daily , Securities Exchange Commission , Kiniksa Pharmaceuticals Stock Performance , China Universal Asset Management Co , Kiniksa Pharmaceuticals Company Profile , Dynamic Technology Lab Private Ltd , Victory Capital Management Inc , Hedge Funds Weigh In On Kiniksa Pharmaceuticals , Kiniksa Pharmaceuticals Ltd , Free Report , Get Free Report , Exchange Commission , Universal Asset Management , Capital Management , Technology Lab Private Ltd , Kiniksa Pharmaceuticals Daily , Nasdaq Knsa , Boost Price Target , Evercore Isi ,

Wedbush Reaffirms "Outperform" Rating for Kiniksa Pharmaceuticals (NASDAQ:KNSA)

Wedbush reaffirmed their outperform rating on shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA – Free Report) in a research note published on Tuesday morning, RTT News reports. They currently have a $30.00 price objective on the stock. Wedbush also issued estimates for Kiniksa Pharmaceuticals’ Q2 2024 earnings at ($0.06) EPS, Q3 2024 earnings at ($0.02) EPS, Q4 […] ....

Michaelr Megna , News Ratings For Kiniksa Pharmaceuticals Daily , Capital Management Inc , Kiniksa Pharmaceuticals Ltd , Dynamic Technology Lab Private Ltd , Institutional Trading Of Kiniksa Pharmaceuticals , Kiniksa Pharmaceuticals , Advisors Inc , Kiniksa Pharmaceuticals Trading , Kiniksa Pharmaceuticals Company Profile , Victory Capital Management Inc , China Universal Asset Management Co , Free Report , Get Free Report , Universal Asset Management , Capital Management , Technology Lab Private Ltd , Kiniksa Pharmaceuticals Daily , Nasdaq Knsa , Reiterated Rating ,

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Forecasted to Post Q2 2024 Earnings of ($0.06) Per Share

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Forecasted to Post Q2 2024 Earnings of ($0.06) Per Share
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sanjk Patel , Michaelr Megna , News Ratings For Kiniksa Pharmaceuticals Daily , Kiniksa Pharmaceuticals Company Profile , Kiniksa Pharmaceuticals Ltd , Granahan Investment Management , Institutional Trading Of Kiniksa Pharmaceuticals , Parkman Healthcare Partners , Opaleye Management Inc , Allspring Global Investments Holdings , Hennion Walsh Asset Management Inc , Kiniksa Pharmaceuticals , Kiniksa Pharmaceuticals Price Performance , Securities Exchange Commission , Free Report , Kiniksa Pharmaceutical , Get Free Report , Global Investments Holdings , Walsh Asset Management , Healthcare Partners , Investment Management , Exchange Commission , Kiniksa Pharmaceuticals Daily ,

Evercore ISI Boosts Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00

Evercore ISI Boosts Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Michaelr Megna , Kiniksa Pharmaceuticals Stock Performance , Kiniksa Pharmaceuticals Ltd , Allspring Global Investments Holdings , Hennion Walsh Asset Management Inc , Securities Exchange Commission , Institutional Trading Of Kiniksa Pharmaceuticals , Kiniksa Pharmaceuticals Company Profile , Kiniksa Pharmaceuticals , News Ratings For Kiniksa Pharmaceuticals Daily , Parkman Healthcare Partners , Granahan Investment Management , Opaleye Management Inc , Get Free Report , Exchange Commission , Global Investments Holdings , Walsh Asset Management , Healthcare Partners , Investment Management , Kiniksa Pharmaceuticals Daily ,